APPLICATION
ANDA204304
TYPE
ANDA
ORIGINAL APPROVAL
2017-01-05
LATEST ACTION
2023-01-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
FINASTERIDEPrescription
FINASTERIDE 5MG · TABLET · ORAL
Approval history
2023-01-17Labeling · Supplement 8 · standardAP
2023-01-17Labeling · Supplement 11 · standardAP
2023-01-17Labeling · Supplement 9 · standardAP
2017-03-08Manufacturing (CMC) · Supplement 1 · unknownAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.